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Systemic Lupus Erythematosus, or SLE, is a chronic 
autoimmune disease which significantly affects various 
organs of the body and the oral cavity. According to 
various studies, SLE can cause an increased risk of 
periodontitis, fungal infections, and dental caries within the 
oral cavity. Periodontitis is an inflammatory condition 
mediated by an infectious etiology which affects the 
supporting tissues of the periodontium and alveolar bone. 
With SLE being an inflammatory condition as well, recent 
studies have emerged hypothesizing the possible 
association between SLE and periodontitis. Other effects 
on the oral cavity such as fungal infections including lichen 
planus and angular cheilitis are occasionally seen in 
patients with lupus. Furthermore, SLE has been shown to 
increase the prevalence of dental caries due to decreased 
salivary flow and pH, and subsequent changes in the oral 
flora. On a systemic level, internal inflammation of SLE 
could lead to several other problems within the body and 
certain medications patients take for SLE treatment can 
cause cutaneous lesions. Therefore, as clinicians, it is 
imperative to adequately review patient medical histories 
as well as perform intraoral and extraoral examinations in 
order to fully understand the possible contraindications 
between dental treatment and SLE.  
The purpose of this literature review is to inform clinicians 
on the oral and systemic aspects of SLE and how 
evidence-based decision making may impact dental 
treatment planning in order to provide patients with the 
best quality of care.
Systemic Lupus Erythematosus, or SLE, is a chronic 
autoimmune inflammatory disease affecting the central 
nervous system, the heart, lungs, kidneys and skin. Some 
of the most common symptoms seen with this disease 
include the malar, or butterfly, rash, joint pain and swelling, 
loss of appetite, nausea, etc. The etiology of SLE is not 
completely known, but this autoimmune disease is more 
prevalent among women of child bearing age. Since there 
is no cure for SLE, the goal of treatment is to relieve 
symptoms and protect organs by decreasing internal 
inflammation.1
SLE and Periodontitis
In a recent study, an analysis was done comparing the 
frequency and severity of chronic periodontitis between SLE 
patients and non-SLE patients. After measuring plaque index, 
BOP, probing depths, and attachment levels on both groups, 
the researchers determined the severity of periodontal disease 
was about the same, but chronic periodontitis occurred at an 
earlier age in SLE patients.2
In another study, researchers found a significant elevation in 
anaerobic bacteria such as Prevotella, Selenomonas, and 
Treponema, in SLE patients by extracting DNA from endodontic 
paper points placed in their deepest pockets. A positive 
correlation has been found between SLE patients and the “red 
complex” periodontal pathogens as well.3
SLE and Fungal Infections 
SLE patients may experience angular cheilitis, with severe 
crusting around their lips which is most often asymptomatic.4 It 
is possible for patients to present with erosive lichen planus as 
well with the most common areas being the buccal mucosa, 
hard palate, and lower lip.5 Invasive fungal infections as a whole 
serve as a major problem for these patients, causing an 
increased risk of mortality and increased hospital readmission.6 
SLE and Dental Caries 
A cross-sectional study was conducted and determined a strong 
correlation between SLE patients and certain risk factors for 
dental caries including a substantial decrease in salivary flow, a 
more acidic oral pH, and an increase in cariogenic bacteria 
including S. mutans and S. sobrinus. 7
SLE has the potential to cause serious organ 
inflammation throughout the body including the muscles, 
blood vessels, and the lining of the lungs and kidneys. In 
addition to internal inflammation, there is a risk of 
leukopenia and thrombocytopenia, causing an increased 
risk of infection and bleeding respectively.1 There are 
potential adverse effects from prolonged use of a 
specific SLE medication Hydroxychloroquine, or HCQ, 
one effect being cutaneous lesions.8 Along with this, 
another adverse effect of HCQ is hyperpigmentation of 
the lips and gingiva.9
As clinicians it is pertinent to thoroughly review over 
medical histories, perform adequate extraoral and 
intraoral examinations, and provide the best quality of 
care for patients suffering with SLE. Intraoral 
examinations are of particular importance due to oral 
ulcerations being present in about 9-45% of SLE 
patients and xerostomia being likely if the disease 
affects the salivary glands.10
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Fig 1. Distribution of 75 SLE patients and 
75 control subjects with an without chronic 
periodontitis according to age.2
Fig. 1. Possible mechanisms associating Toll-like receptor 
with systemic lupus erythematosus and periodontal 
disease.11
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Abstract 
Systemic Lupus Erythematosus, or SLE, is a chronic autoimmune disease which significantly 
affects various organs of the body and the oral cavity. According to various studies, SLE can 
cause an increased risk of periodontitis, fungal infections, and dental caries within the oral 
cavity. Periodontitis is an inflammatory condition mediated by an infectious etiology which 
affects the supporting tissues of the periodontium and alveolar bone. With SLE being an 
inflammatory condition as well, recent studies have emerged hypothesizing the possible 
association between SLE and periodontitis. Other effects on the oral cavity such as fungal 
infections including lichen planus and angular cheilitis are occasionally seen in patients with 
lupus. Furthermore, SLE has been shown to increase the prevalence of dental caries due to 
decreased salivary flow and pH, and subsequent changes in the oral flora. On a systemic level, 
internal inflammation of SLE could lead to several other problems within the body and certain 
medications patients take for SLE treatment can cause cutaneous lesions. Therefore, as 
clinicians, it is imperative to adequately review patient medical histories as well as perform 
intraoral and extraoral examinations in order to fully understand the possible contraindications 
between dental treatment and SLE. The purpose of this literature review is to inform clinicians 
on the oral and systemic aspects of SLE and how evidence-based decision making may impact 
dental treatment planning in order to provide patients with the best quality of care.   
 
 
 
 
Introduction 
Systemic Lupus Erythematosus, or SLE, is a chronic autoimmune inflammatory disease 
which significantly affects various organs of the body and the oral cavity.1  SLE is the systemic 
form of lupus and directly affects multiple areas in the body, including the central nervous 
system, the heart, lungs, kidneys, and the skin. With SLE being categorized as an autoimmune 
disease, this complex and potentially severe condition attacks healthy cells, tissues, and organs, 
resulting in chronic inflammation. There is no cure for systemic lupus erythematosus at the 
present time. However, the goal of treatment is to relieve the symptoms of the disease and 
protect internal organs by decreasing the amount of inflammation within the body. Common 
symptoms of people suffering from SLE include joint pain and swelling, loss of appetite, nausea, 
muscle aches, and severe fatigue. Most people suffering from SLE will develop arthritis during 
the course of the disease, and this form of arthritis mimics another autoimmune disease known as 
rheumatoid arthritis.2  However, the most notable symptom of people with lupus in general is the 
skin rash over the nose and cheeks termed the malar rash, otherwise known as the butterfly rash. 
This non painful rash can be precipitated or even worsened by a process called photosensitivity, 
or exposure to sunlight. Photosensitivity could even cause what’s called a “flare” of SLE, which 
is characterized by increased inflammation throughout the body.2  In addition to the malar rash, 
other areas of the skin exposed to sunlight can be susceptible to a rash too.3  
The etiology of SLE is not completely known but some suggest it may be related to 
genetic, environmental, or hormonal factors. The strongest risk factor of this disease is gender, 
with SLE being more prevalent among women of child-bearing age between age 20 to 45, and a 
male to female ratio of 1:8.2  Certain people are more at risk than others in developing SLE 
including people of African American, Hispanic, and Asian descent.3  Due to the ability to detect 
lupus at earlier stages, the incidence of lupus has significantly increased over the past 40 years.4 
On a broad scale, there are approximately 16,000 new cases of lupus are diagnosed every year 
and five million people suffer from this disease worldwide. Unfortunately there is no single test 
to diagnose SLE, so in order to diagnose someone with this condition, one has to rule out other 
autoimmune diseases with the same symptoms such as rheumatoid arthritis.3 
Luckily, the American College of Rheumatology has developed eleven specific criteria in 
order to effectively diagnosis people with SLE. Along with rheumatologists, neurologists, 
immunologists, etc., oral health care professionals are an additional key asset to this 
interprofessional group due to the oral manifestations seen in patients with SLE.2 Due to the 
numerous effects systemic lupus erythematosus can have on the body, the purpose of this 
literature review is to inform clinicians on the oral and systemic aspects of SLE and how 
evidence-based decision making may impact dental treatment planning in order to provide 
patients with the best quality of care. All of the studies and additional information discussed in 
this review of literature were primarily found on PubMed and serve to backup all of the claims 
regarding SLE and its effects on the oral cavity and the body as a whole.  
 
SLE and Periodontitis  
 In regards to SLE and its effects on the oral cavity, many studies have shown a possible 
association between systemic lupus erythematosus and periodontitis. Periodontitis is an 
inflammatory condition mediated by an infectious etiology which affects the supporting tissues 
of the periodontium and alveolar bone. The accumulation of dental plaque initiates gingival 
inflammation, leading to anaerobic bacterial colonization and loss of periodontal attachment and 
possible tooth loss. Certain bacteria known as the “red complex” organisms serve as the 
infectious etiology of periodontitis, which include Porphyromonas gingivalis, Tannerella 
forsythia, and Treponema denticola.1 This subgingival microbiota increases the severity of the 
periodontal disease as well as local inflammation.5  With SLE being an inflammatory condition 
as well, recent studies have emerged hypothesizing the possible association between SLE and 
periodontitis.  
In fact, the prevalence of periodontitis in patients with SLE varies, ranging from 60 to 
about 93.8%. In a recent study, an analysis was done to compare the frequency and severity of 
chronic periodontitis between seventy-five patients with SLE to seventy-five patients without 
SLE or any rheumatic disease. They measured plaque index of all patients and various indicators 
of periodontal disease including probing depth, clinical attachment level, and bleeding on 
probing. Out of the seventy-five patients in the group with SLE, fifty-one of them had chronic 
periodontitis and forty-one of the seventy-five people without SLE had chronic periodontitis. 
The severity of the disease in both groups was about the same, however, chronic periodontitis 
occurred earlier for patients with SLE. Overall, the likelihood of developing chronic periodontitis 
was systematically higher for the patients with SLE, especially at younger ages.6  
Similar to this study, a systematic review and meta-analysis was conducted using various 
publications to determine another possible association between periodontitis and systemic lupus 
erythematosus. A total of 1,383 patients were studied, with 487 having SLE and 896 without 
SLE. These patients were observed in multiple observational studies of cross-sectional, case-
control, or cohort design. After doing a meta-analysis, the researchers found the overall risk of 
contracting periodontitis in SLE patients was significantly greater than patients without SLE with 
a risk ratio of 1.76. However, this study did not find any significant association in regards to the 
specific indicators of periodontitis including pocket depth, clinical attachment loss, or bleeding 
on probing. From these results, the researchers concluded further longitudinal studies need to be 
conducted to actually confirm the association between SLE and periodontitis.1 
Research has shown periodontal treatment can reduce the symptoms of SLE by reducing 
the expression of Toll-Like Receptors (TLRs).  TLRs are sensing proteins of the innate immune 
system which trigger the inflammatory response to bacterial invasion.7 Studies have shown 
significant elevations in anaerobic bacteria such as Prevotella, Selenomonas, and Treponema in 
patients with SLE.  In a recent study, the subgingival microbiota was measured in both SLE 
patients and healthy subjects to determine if there is a link between periodontal disease and SLE.  
Researchers found a significant elevation in anaerobic bacteria in SLE patients while there was 
an increase in abundance of aerobic bacteria in non-SLE patients.  This was achieved by placing 
endodontic paper points into sites with the deepest pockets for one minute each.  DNA was then 
extracted from the samples and sequenced.   Positive correlations were found between SLE 
patients and the “red complex” periodontal pathogens T. denticola, P. gingivalis, and T. 
forsythia.6   
 
 
SLE and Fungal Infections 
In addition to an increased risk of periodontitis, patients with SLE may experience fungal 
infections such as angular cheilitis, lichen planus, and invasive fungal infections as a whole. SLE 
patients with angular cheilitis will commonly experience severe crusting around their lips, often 
times being painless.  These mucocutaneous lesions can present themselves in a variety of ways 
including keratotic, bullous, or varrucous lesions.8 Furthermore, about 45% of patients with SLE 
have oral mucosa involvement including erythema in multiple sites. Although less common than 
erythemic sites, it is possible for SLE patients to present cases of fungal infections such as 
erosive oral lichen planus.9 The most common areas for lesions include the buccal mucosa, hard 
palate, and lower lip.8  
Invasive fungal infections as a whole prose a major problem for patients with SLE, with 
infections of the respiratory and urinary tracts, and blood causing about 30% of deaths. With an 
increased risk of mortality and a higher prevalence of hospital readmission, these infections tend 
to worsen patient prognosis and are associated with patients who have a greater disease severity. 
In order to determine the commonness and risks associated between invasive fungal infections 
and SLE, a cross-sectional study was conducted among Colombian patients with systemic lupus 
erythematosus. This study included two-hundred subjects and was conducted over a six year 
period with 84.5% of the patients being women with the median age being thirty-six years old. 
There was a median diagnosis of forty-one months, with medications and comorbidities of the 
patients recorded in the beginning of the study. In result, fifteen patients presented with invasive 
fungal infections. The researchers in this study found Candida albicans being the most 
frequently isolated fungal microorganism, followed by Candida tropicalis, predominantly found 
in blood sites. Other fungal microorganisms found in this study include Histoplasma 
capsullatum, Candida glabrata, and Cryptococcus neoformans. When referring to the increased 
risk of mortality, patients with SLE who suffered from invasive fungal infections as well had a 
9.91 times higher risk of mortality than SLE patients without these fungal infections.10  
 
SLE and Dental Caries 
Not only does SLE have an association with periodontitis and fungal infections, this 
disease in fact has an association with an increased prevalence of dental caries as well. Dental 
caries is the most prevalent oral disease, affecting people from all over the world. There are 
several risk factors associated with dental caries, with these factors being assessed in patients 
with SLE in a current observational cross-sectional blind study. Some specific dental caries risk 
factors researchers assessed during this study included salivary flow, pH, buffer capacity, and 
presence of cariogenic bacteria. The frequency of dental caries were assessed among 60 
participants with SLE, either in active or inactive forms of SLE, divided equally into two groups 
of 30 subjects each. Two indexes were used in this study to analyze dental caries including the 
decayed, missing, and filled teeth, or DMFT index, and the Integrative Dental Caries Index, or 
IDCI.11  
The researchers of this cross-sectional study found a strong positive correlation between 
active SLE patients and the specific risk factors for dental caries including a decrease in salivary 
flow, a change in oral pH, and the quantity of cariogenic bacteria, such as Streptococcus mutans 
and Streptococcus sobrinus. The two factors with the most vital role in the high caries activity of 
patients with lupus included salivary flow and pH. In active SLE, those patients had a more 
substantial decrease in salivary flow and a significantly more acidic salivary pH. Moreover, the 
researchers determined most patients who suffer with SLE suffer from certain oral complaints as 
well which are associated with a decrease in salivary flow, with the prevalence in this study 
being 85%.11 
 
SLE on a Systemic Level 
On a more systemic level, with SLE being an inflammatory condition, some serious 
organ inflammation could occur in the brain, liver, and kidneys. There is a potential for 
leukopenia, or a decrease in white blood cell count, and thrombocytopenia, or low platelet count, 
in patients with SLE. The risk of both leukopenia and thrombocytopenia involves an increased 
risk of infection and an increased risk of bleeding, respectively. Other areas prone to 
inflammation within the body seen in SLE patients include muscles, blood vessels, the lining of 
the lungs, and kidneys. When lupus starts to involve the brain, this could lead to personality 
changes, possible seizures, and nerve damage.2  
In terms of treatment for SLE, certain medications patients take can cause cutaneous 
lesions and possibly contribute to development of periodontal disease prematurely.   Treatment 
of SLE is primarily directed toward decreasing the amount of inflammation or the level of 
autoimmune activity with certain anti-inflammatory drugs for people with mild symptoms, and 
corticosteroids tend to be used for people with more severe forms of SLE.2  In regards to specific 
medications patients with SLE might take, recent studies showed a high correlation between the 
presence of pathogens like Fusobacterium and P. gingivalis and the dosage of prednisone.5 
Furthermore, in some patients cutaneous lesions could result, either from taking 
Hydroxychloroquine (HCQ), an antimalarial drug used to treat SLE, as a result of increased 
disease.12  Medication cessation should be completed with a referral to a dermatologist to 
determine the cause of lesions. The cause of the reaction due to HCQ is unknown and may be 
due to the imbalance of the immune system in the early initiation of the drug. The 
recommendations by the dermatologist can vary depending on the severity of cutaneous lesions 
and whether or not the reaction has an effect on the systemic condition of the patient.12 Another 
adverse effect of HCQ can be hyperpigmentation on the lips and gingiva after a long duration of 
medication intake. A cross-sectional study of forty-one patients was conducted to determine the 
possibility of hyperpigmentation in systemic disease. Of the forty-one cases, 73.2% of them were 
prescribed the hydroxychloroquine to treat SLE. After thirty-two months of hydroxychloroquine 
treatment pigmented lesions were noted in the lower limbs, face, lips, and gingiva of the SLE 
patients. Only the SLE patients who participated in this study presented with 
hydroxychloroquine hyperpigmentation, which suggests hydroxychloroquine pigmentation may 
be more frequent in SLE patients than in other diseases.13 
 
Conclusion 
As clinicians, it is imperative to adequately review patient medical histories as well as 
perform extraoral and intraoral examinations in order to fully understand the possible 
contraindications between dental treatment and SLE. Upon discovering the presence of SLE in a 
patient, it is important to understand the increased risk of myocardial infarction to help prevent 
medical emergencies. According to a cross-sectional study, an increase of endothelial 
microparticles is found in SLE patients. Endothelial microparticles trigger neutrophil activation 
and coagulation which in turn triggers inflammation causing endothelial vascular issues which 
may lead to myocardial infarction.14  It is important for a clinician to be well versed in the 
medications these patients are taking for SLE and whether there is a need for possible medication 
cessation. Equally important to adequately reviewing over SLE patient’s medical history, it is 
obligatory to efficiently complete an extra-oral examination as well to find possible cutaneous 
lesions, and hyperpigmentation caused by SLE medications.12 Similar to providing extra-oral 
examinations, intra-oral examinations are an additional necessity for these patients considering 
oral ulcerations may be present, and are in fact present in nine to forty-five percent of the people 
suffering from lupus according to the European Journal of Dermatology. However, the initial 
diagnosis of these oral ulcerations may require a biopsy and collaborate work with a 
rheumatologist to determine whether or not these ulcerations are caused from lupus itself. 
Another important thing to keep in mind as clinicians when it comes to lupus is some patients 
might experience xerostomia if it affects their salivary glands, so providing fluoride varnishes to 
these patients might be a necessity and they could be at a higher caries rate compared to other 
patients.3 
 A recent study investigated the oral health quality of life in patients with SLE.  
Researchers found patients with SLE have a lower oral health quality of life mainly due to the 
increased need for oral prosthesis wearing.  Due to the increased periodontal bone loss in these 
patients, it is fairly common among patients with SLE to lose teeth and require partial dentures. 
Studies have shown an increase in mouth sores and ulcers due to ill-fitting dentures, thus 
lowering their quality of life.15 It is important to recognize and understand all of the effects of 
SLE on the oral cavity and the entire body in order to provide the best quality care for patients 
living with this autoimmune inflammatory disease.  
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